Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HTLV-I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04301076
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT00773292
What this trial is testing

Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)

Who this might be right for
HTLV I Associated Myelopathy
Imperial College London 7
Very early researchStudy completedNCT01867320
What this trial is testing

Raltegravir for HAM/TSP

Who this might be right for
HTLV-I Infection
National Institute of Neurological Disorders and Stroke (NINDS) 19
Not applicableStudy completedNCT01941680
What this trial is testing

High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant

Who this might be right for
T-cell LymphomaLeukaemia
University Hospital Center of Martinique 20
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Study completedNCT05240612
What this trial is testing

A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Who this might be right for
HTLV-1-Associated Myelopathy (HAM)
Tanabe Pharma Corporation 15
Not applicableLooking for participantsNCT00001778
What this trial is testing

Evaluation of Patients With HAM/TSP

Who this might be right for
HTLV-I InfectionTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS) 750
Testing effectiveness (Phase 2)Study completedNCT01000285
What this trial is testing

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

Who this might be right for
Leukemia-Lymphoma, Adult T-Cell
Washington University School of Medicine 18
Testing effectiveness (Phase 2)Looking for participantsNCT04799288
What this trial is testing

Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis

Who this might be right for
HAM/TSP
National Institute of Neurological Disorders and Stroke (NINDS) 24
Post-approval studies (Phase 4)Study completedNCT01418430
What this trial is testing

Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

Who this might be right for
HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
King's College Hospital NHS Trust
Early research (Phase 1)Study completedNCT00076843
What this trial is testing

Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Who this might be right for
HTLV-1
National Institute of Neurological Disorders and Stroke (NINDS) 9
Not applicableEnded earlyNCT00519181
What this trial is testing

Safety and Efficiency Study of Valproic Acid In HAM/TSP

Who this might be right for
HTLV-I-Associated Myelopathy
University Hospital Pierre Zobda-Quitman 19
Testing effectiveness (Phase 2)Looking for participantsNCT07555431
What this trial is testing

Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection

Who this might be right for
HTLV-1 InfectionHTLV I Associated MyelopathiesHTLV I Associated T Cell Leukemia Lymphoma+1 more
Carlos Brites 146
Not applicableStudy completedNCT04830319
What this trial is testing

Pilates Method in People With HAM/TSP

Who this might be right for
HAM/TSPHTLV-1 Secondary MyelopathyBalance+2 more
Pedreira, Érika, M.D. 22
Not applicableStudy completedNCT00339807
What this trial is testing

Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica

Who this might be right for
HTLV-I
National Cancer Institute (NCI) 1,500
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Testing effectiveness (Phase 2)Study completedNCT00001785
What this trial is testing

Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)

Who this might be right for
HTLV-I InfectionSpinal Cord DiseaseTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS) 12
Testing effectiveness (Phase 2)Looking for participantsNCT06698003
What this trial is testing

Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Who this might be right for
T-Cell Leukemia/Lymphoma, AdultT-cell Leukemia/LymphomaT-cell Leukemia+1 more
Memorial Sloan Kettering Cancer Center 134
Not applicableStudy completedNCT02877030
What this trial is testing

Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus

Who this might be right for
HTLV-1
Pedreira, Érika, M.D. 42
Next Page